<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35073673</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0376-2491</ISSN><JournalIssue CitedMedium="Print"><Volume>102</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Zhonghua yi xue za zhi</Title><ISOAbbreviation>Zhonghua Yi Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Evaluation of vestibular-evoked myogenic potential for functional integrity of the brain stem in Kennedy's disease].</ArticleTitle><Pagination><StartPage>255</StartPage><EndPage>260</EndPage><MedlinePgn>255-260</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112137-20210606-01290</ELocationID><Abstract><AbstractText><b>Objective:</b> To investigate whether vestibular-evoked myogenic potentials(VEMPs) can be used to assess brainstem involvement in patients with Kennedy's disease (KD). <b>Method:</b> This was a case-control study.Twenty consecutive patients with genetically confirmed KD and 20 age-and sex-matched healthy subjects were enrolled from November 2018 to September 2020.All subjects were tested for three types of VEMPs, including cervical VEMP (c-VEMP) recorded by the sternocleidomastoid muscle (parameter:p13, n23), masseter VEMP (m-VEMP) recorded by the masseter muscle(parameter: p11), and ocular VEMP (o-VEMP) recorded by the inferior oblique muscle (parameter n10, p15).The latency of each wave, interside peak latency and interpeak latency of c-VEMP, the corrected amplitude and amplitude asymmetry ratio were recorded. Bilateral sternocleidomastoid muscle (SCMM) electromyography (EMG) was performed. The spinal cord and bulbous muscular atrophy functional rating scale (SBMAFRS) was used for assessment. <b>Results:</b> The mean p13 latency of c-VEMP was (15.5&#xb1;1.4)ms, which was longer than that of the control group[(13.3&#xb1;0.9)ms](<i>P</i>&lt;0.05); the mean n23 latency was(25.5&#xb1;1.4)ms, which was also longer than that of the control group[(22.5&#xb1;1.0)ms] (<i>P</i>&lt;0.05); the difference of bilateral p13[(2.3&#xb1;0.6)ms] was significantly higher than that of the control group(<i>P</i>&lt;0.05). The abnormal rates of c-, m-, o-VEMP in KD patients were 75%(15/20), 30%(6/20) and 20%(4/20), respectively. There was a significant positive correlation between c-VEMP latency and course of disease in KD patients(left: <i>r</i>=0.715, 0.695, right: <i>r</i>= 0.708, 0.715, both <i>P</i>&lt;0.05). However, c-VEMP latency was negatively correlated with SBMAFRS score (left: <i>r</i>=-0.701, -0.694, right: <i>r</i>=-0.644, -0.685, both <i>P</i>&lt;0.05). Abnormal rates of SCMM EMG in KD group were as follows: 15%(3/20)of patients showed spontaneous potential in resting state and 45% (9/20) of patients exhibited simple recruitment. <b>Conclusions:</b> The c-VEMP latency is a sensitive tool for detecting lower brainstem involvement in patients with KD, and the degree of damage increases with prolongation of disease course. The o-and m-VEMP abnormalities indicate that some KD patients develop upper brainstem damage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>X X</ForeName><Initials>XX</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Changchun Central Hospital, Changchun 130000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Y S</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Y M</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>D S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>81873784</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Yi Xue Za Zhi</MedlineTA><NlmUniqueID>7511141</NlmUniqueID><ISSNLinking>0376-2491</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000161" MajorTopicYN="N">Acoustic Stimulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058585" MajorTopicYN="Y">Vestibular Evoked Myogenic Potentials</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b> &#x63a2;&#x8ba8;&#x524d;&#x5ead;&#x8bf1;&#x53d1;&#x808c;&#x6e90;&#x6027;&#x7535;&#x4f4d;&#xff08;VEMPs&#xff09;&#x662f;&#x5426;&#x53ef;&#x7528;&#x4e8e;&#x80af;&#x5c3c;&#x8fea;&#x75c5;&#xff08;KD&#xff09;&#x8111;&#x5e72;&#x53d7;&#x7d2f;&#x8bc4;&#x4f30;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b> &#x672c;&#x7814;&#x7a76;&#x4e3a;&#x75c5;&#x4f8b;&#x5bf9;&#x7167;&#x7814;&#x7a76;&#xff0c;&#x6536;&#x96c6;&#x5317;&#x4eac;&#x5927;&#x5b66;&#x7b2c;&#x4e09;&#x533b;&#x9662;&#x81ea;2018&#x5e74;11&#x6708;&#x81f3;2020&#x5e74;9&#x6708;KD&#x60a3;&#x8005;20&#x4f8b;&#xff08;KD&#x7ec4;&#xff09;&#xff0c;&#x5e74;&#x9f84;&#x548c;&#x6027;&#x522b;&#x5339;&#x914d;&#x7684;&#x5065;&#x5eb7;&#x53d7;&#x8bd5;&#x8005;20&#x540d;&#xff08;&#x5065;&#x5eb7;&#x5bf9;&#x7167;&#x7ec4;&#xff09;&#x3002;&#x6240;&#x6709;&#x53d7;&#x8bd5;&#x8005;&#x5747;&#x68c0;&#x6d4b;&#x4e09;&#x79cd;&#x7c7b;&#x578b;VEMPs&#xff0c;&#x5305;&#x62ec;&#x80f8;&#x9501;&#x4e73;&#x7a81;&#x808c;&#xff08;SCMM&#xff09;&#x8bb0;&#x5f55;&#x7684; c-VEMP&#xff0c;&#x53c2;&#x6570;p13&#x3001;n23&#xff1b;&#x54ac;&#x808c;&#x8bb0;&#x5f55;&#x7684;m-VEMP&#xff0c;&#x53c2;&#x6570;p11&#xff1b;&#x4e0b;&#x659c;&#x808c;&#x8bb0;&#x5f55;&#x7684;o-VEMP&#xff0c;&#x53c2;&#x6570;n10&#x3001;p15&#xff1b;&#x8bb0;&#x5f55;&#x5404;&#x6ce2;&#x7684;&#x6f5c;&#x4f0f;&#x671f;&#xff0c;c-VEMP&#x6ce2;&#x95f4;&#x671f;&#x3001;&#x4e24;&#x4fa7;&#x5dee;&#xff0c;&#x6821;&#x6b63;&#x6ce2;&#x5e45;&#x53ca;&#x6ce2;&#x5e45;&#x975e;&#x5bf9;&#x79f0;&#x6bd4;&#xff1b;&#x540c;&#x65f6;&#x884c;&#x53cc;&#x4fa7;SCMM&#x9488;&#x6781;&#x808c;&#x7535;&#x56fe;&#x68c0;&#x6d4b;&#xff1b;&#x5e76;&#x4f7f;&#x7528;&#x810a;&#x9ad3;&#x548c;&#x7403;&#x90e8;&#x808c;&#x8089;&#x840e;&#x7f29;&#x529f;&#x80fd;&#x8bc4;&#x5b9a;&#x91cf;&#x8868;&#xff08;SBMAFRS&#xff09;&#x8bc4;&#x4f30;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b> KD&#x7ec4;&#x60a3;&#x8005;c-VEMP&#x7684;p13&#x6f5c;&#x4f0f;&#x671f;&#xff3b;&#xff08;15.5&#xb1;1.4&#xff09;ms&#xff3d;&#x548c;n23&#x6f5c;&#x4f0f;&#x671f;&#xff3b;&#xff08;25.5&#xb1;1.4&#xff09;ms&#xff3d;&#x5747;&#x660e;&#x663e;&#x957f;&#x4e8e;&#x5065;&#x5eb7;&#x5bf9;&#x7167;&#x7ec4;&#xff3b;&#xff08;13.3&#xb1;0.9&#xff09;ms&#xff0c;&#xff08;22.5&#xb1;1.0&#xff09;ms&#xff3d;&#xff08;&#x5747;<i>P</i>&lt;0.05&#xff09;&#xff1b;&#x53cc;&#x4fa7;P13&#x5dee;&#x503c;&#xff3b;&#xff08;2.3&#xb1;0.6&#xff09;ms&#xff3d;&#xff0c;&#x4e0e;&#x5065;&#x5eb7;&#x5bf9;&#x7167;&#x7ec4;&#x6bd4;&#x8f83;&#x5dee;&#x5f02;&#x6709;&#x7edf;&#x8ba1;&#x5b66;&#x610f;&#x4e49;&#xff08;<i>P</i>&lt;0.05&#xff09;&#x3002;KD&#x60a3;&#x8005;c-&#x3001;m-&#x3001;o-VEMP&#x7684;&#x5f02;&#x5e38;&#x7387;&#x5206;&#x522b;&#x4e3a;75%&#xff08;15/20&#xff09;&#xff0c;30%&#xff08;6/20&#xff09;&#xff0c;20%&#xff08;4/20&#xff09;&#x3002;KD&#x60a3;&#x8005;c-VEMP&#x6f5c;&#x4f0f;&#x671f;&#x4e0e;&#x75c5;&#x7a0b;&#x5448;&#x6b63;&#x76f8;&#x5173;&#xff08;&#x5de6;&#xff1a;<i>r</i>=0.715&#x3001;0.695&#xff0c;&#x53f3;&#xff1a;<i>r</i>=0.708&#x3001;0.715&#xff0c;&#x5747;<i>P</i>&lt;0.05&#xff09;&#xff1b;&#x4e0e;SBMAFRS&#x8bc4;&#x5206;&#x5448;&#x8d1f;&#x76f8;&#x5173;&#xff08;&#x5de6;&#xff1a;<i>r</i>=-0.701&#xff0c;-0.694&#xff0c;&#x53f3;&#xff1a;<i>r</i>=-0.644&#xff0c;-0.685&#xff0c;&#x5747;<i>P</i>&lt;0.05&#xff09;&#x3002;KD&#x7ec4;SCMM&#x9488;&#x6781;&#x808c;&#x7535;&#x56fe;&#x7684;&#x5f02;&#x5e38;&#x7387;&#xff1a;&#x5b89;&#x9759;&#x72b6;&#x6001;&#x4e0b;&#x51fa;&#x73b0;&#x81ea;&#x53d1;&#x7535;&#x4f4d;&#x8005;15%&#xff08;3/20&#xff09;&#x3001;&#x5927;&#x529b;&#x6536;&#x7f29;&#x52df;&#x96c6;&#x5355;&#x7eaf;&#x76f8;&#x8005;45%&#xff08;9/20&#xff09;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b> c-VEMP&#x7684;&#x6f5c;&#x4f0f;&#x671f;&#x662f;&#x68c0;&#x6d4b;KD&#x7403;&#x90e8;&#x529f;&#x80fd;&#x53d7;&#x7d2f;&#x7684;&#x654f;&#x611f;&#x5de5;&#x5177;&#xff0c;&#x635f;&#x4f24;&#x7a0b;&#x5ea6;&#x968f;&#x75c5;&#x7a0b;&#x5ef6;&#x957f;&#x800c;&#x52a0;&#x91cd;&#x3002;o-VEMP&#x548c;m-VEMP&#x7684;&#x635f;&#x4f24;&#x8868;&#x660e;&#x90e8;&#x5206;KD&#x60a3;&#x8005;&#x51fa;&#x73b0;&#x4e0a;&#x8111;&#x5e72;&#x53d7;&#x7d2f;&#x3002;.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>25</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35073673</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn112137-20210606-01290</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>